MENU

CLLS Cellectis SA Forecast, Technical & Fundamental Analysis

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications... Show more

Industry: #Biotechnology
CLLS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
CLLS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CLLS is expected to report earnings to rise 46.67% to -26 cents per share on July 30

Cellectis SA CLLS Stock Earnings Reports
Q2'26
Est.
$-0.26
Q1'26
Beat
by $0.08
Q4'25
Beat
by $0.03
Q3'25
Beat
by $0.24
Q2'25
Missed
by $0.02
The last earnings report on May 11 showed earnings per share of -18 cents, beating the estimate of -25 cents. With 100.00 shares outstanding, the current market capitalization sits at 312.83M.
A.I. Advisor
published General Information

General Information

a genome engineering company of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
8, rue de la Croix Jarry
Phone
+33 181691600
Employees
186
Web
https://www.cellectis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCSUX35.74N/A
N/A
Goldman Sachs Small Cap Eq Insghts R6
TIRHX20.21N/A
N/A
Nuveen Real Estate Sec Sel I
VPRDX10.12N/A
N/A
VY® Morgan Stanley Global Franchise R6
DEMGX14.47-0.02
-0.14%
DFA Emerging Markets Trgt Val Instl
MDIIX21.02-0.15
-0.71%
iShares MSCI EAFE Intl Idx Inv A

CLLS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
N/A
SLN - CLLS
43%
Loosely correlated
N/A
MDGL - CLLS
40%
Loosely correlated
N/A
PMVP - CLLS
38%
Loosely correlated
N/A
AXON - CLLS
36%
Loosely correlated
N/A
TGTX - CLLS
36%
Loosely correlated
N/A
More
Cellectis SA (CLLS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com